Skip to main content
Glenmark Pharmaceuticals Limited (BOM:532296)
India flag India · Delayed Price · Currency is INR
1,390.10
+21.10 (1.54%)
At close: Apr 22, 2025

Glenmark Pharmaceuticals Revenue

Glenmark Pharmaceuticals had revenue of 33.88B INR in the quarter ending December 31, 2024, with 35.14% growth. This brings the company's revenue in the last twelve months to 139.61B, up 6.10% year-over-year. In the fiscal year ending March 31, 2024, Glenmark Pharmaceuticals had annual revenue of 126.45B with 8.49% growth.

Revenue (ttm)
139.61B
Revenue Growth
+6.10%
P/S Ratio
2.87
Revenue / Employee
9.31M
Employees
14,989
Market Cap
400.96B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024126.45B9.90B8.49%
Mar 31, 2023116.56B-6.49B-5.28%
Mar 31, 2022123.05B13.61B12.44%
Mar 31, 2021109.44B2.87B2.69%
Mar 31, 2020106.57B7.92B8.03%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Reliance Industries 9,398.38B
HDFC Bank 2,728.47B
Tata Consultancy Services 2,553.24B
Bharti Airtel 1,627.08B
ICICI Bank 2,006.54B
State Bank of India 3,409.52B
Infosys 1,647.16B
Bajaj Finance 358.05B
Revenue Rankings

Glenmark Pharmaceuticals News

More News